Replies to post #1672 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

Bear in mind that the threshold for each Mavyret royalty tier is based on the 50% of Mavyret sales attributed to Glecaprevir. E.g., if we say, for the sake of discussion, that the threshold for the second royalty tier is $1B, then it would require $2B of cumulative Mavyret sales for the calendar year to get into that tier.